Genuine question (cos I don't want to be accused again of being a shameless pumper ), isn't a pretty common formula for calculating the share price of a company, use of the equation: SP = Net income divided by total number of shares, times a PE Ratio?
So $540 (net) x 287,000 prescriptions (if the US simply matches Japan) = $155m annual net income
$155m divided by 1.5B shares = $0.10/share
Multiplied by a PE Ratio of 10 = $1.00 per share (I know some have said a PE of 20 or 30 is more usual for biotech, but I'm going conservative).
Am I missing something? If the US sells the same amount of product as Japan, but at the US price of $540 (net), BOT is worth a minimum of $1.00 and that doesn't take into account three times the population, or year-on-year growth, or any of BOT's other products in the pipeline.
Yes?
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-6701
-
-
- There are more pages in this discussion • 2,218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.5¢ |
Change
0.020(5.80%) |
Mkt cap ! $574.9M |
Open | High | Low | Value | Volume |
34.0¢ | 36.5¢ | 33.0¢ | $3.415M | 9.882M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 428471 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 244666 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 428471 | 0.365 |
1 | 13337 | 0.355 |
2 | 42785 | 0.350 |
3 | 262127 | 0.345 |
2 | 900000 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 244666 | 5 |
0.375 | 122527 | 6 |
0.380 | 234798 | 8 |
0.385 | 200020 | 6 |
0.390 | 413990 | 10 |
Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |